Search results
Results from the WOW.Com Content Network
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, wholly owned by the Swiss multinational pharmaceutical company, the Roche Group. It became an independent subsidiary of Roche in 2009.
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
Later, in September, Genentech announced it would acquire Arrayit Corporation. [ 38 ] On 7 April 2014, Roche announced its intention to acquire IQuum for up to $450 million, [ 39 ] as well as the rights to an experimental drug (ORY-1001) from Spanish company Oryzon Genomics for $21 million and up to $500 million in milestone payments. [ 40 ]
Kleiner and Perkins provided $100,000 on the May closing, and acquired 20,000 shares of preferred stock from Genentech. [6] Swanson was made the president and treasurer of Genentech, and received a $2,500 per month salary, along with 25,000 shares. [6] This marked the end of Swanson's unemployment, and the beginning of his career at Genentech ...
Genentech (DNA) -- Swiss pharmaceutical giant Roche said Thursday it has agreed to buy Genentech for $46.8 billion. Genentech's board approved and recommended the deal, which offers $95 per share ...
For premium support please call: 800-290-4726 more ways to reach us
The company completed an initial public offering in March 2001, and prior to its acquisition by Pfizer, it was traded on the Nasdaq Stock Market under the symbol SGEN, and was a component of the Nasdaq-100. As of December 2016, the company has more than 900 employees throughout the United States.
The S&P 500 fell 0.2% to extend the four-day losing streak that dimmed the close of its stellar 2024. The Dow Jones Industrial Average fell 151 points, or 0.4%, after an early gain of 360 points ...